Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

20192,897 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 394, Issue 10193, pp. 121-130

Field-Weighted Citation Impact: 223.57